Virpax Pharmaceuticals, Inc. (VRPX) Financials
VRPX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 13.0 million | 6.5 million |
| 2023-06-30 | 16.0 million | 3.6 million |
| 2023-03-31 | 18.5 million | 3.3 million |
| 2022-12-31 | 19.7 million | 3.1 million |
VRPX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -2.7 million | 195564 |
| 2023-06-30 | -2.2 million | 218257 |
| 2023-03-31 | -2.0 million | 140583 |
| 2022-12-31 | -1.6 million | 138276 |
VRPX Net Income
No data available :(
VRPX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 12.2 million | - | - |
| 2023-06-30 | 14.8 million | - | - |
| 2023-03-31 | 17.0 million | - | - |
| 2022-12-31 | 19.0 million | - | - |
VRPX Shares Outstanding
VRPX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 1.5 million | 4.6 million | - |
| 2023-06-30 | - | 1.3 million | 1.9 million | - |
| 2023-03-31 | - | 1.2 million | 415451 | - |
| 2022-12-31 | - | 1.4 million | 1.7 million | - |
VRPX Cost of Revenue
No data available :(
VRPX
Price: $3.10
52 week price:
Earnings Per Share: -12.97 USD
P/E Ratio: -0.32
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 123600
Market Capitalization: 4.2 million